First Eagle Investment Management LLC reduced its position in Hinge Health Inc. (NYSE:HNGE – Free Report) by 70.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 258,184 shares of the company’s stock after selling 602,100 shares during the period. First Eagle Investment Management LLC’s holdings in Hinge Health were worth $25,106,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. HighTower Advisors LLC purchased a new stake in shares of Hinge Health in the 3rd quarter valued at approximately $241,000. Alberta Investment Management Corp acquired a new position in Hinge Health in the 3rd quarter worth approximately $18,563,000. Virtus Advisers LLC grew its position in Hinge Health by 20.0% during the 3rd quarter. Virtus Advisers LLC now owns 9,472 shares of the company’s stock worth $921,000 after purchasing an additional 1,578 shares in the last quarter. Allworth Financial LP grew its position in Hinge Health by 402.3% during the 3rd quarter. Allworth Financial LP now owns 437 shares of the company’s stock worth $42,000 after purchasing an additional 350 shares in the last quarter. Finally, Russell Investments Group Ltd. raised its stake in Hinge Health by 107.3% during the 3rd quarter. Russell Investments Group Ltd. now owns 292,610 shares of the company’s stock valued at $28,044,000 after purchasing an additional 151,460 shares during the period.
Hinge Health Stock Down 5.5%
Shares of HNGE opened at $114.57 on Wednesday. The company’s fifty day moving average is $104.83 and its 200-day moving average is $71.62. Hinge Health Inc. has a 12 month low of $30.08 and a 12 month high of $126.40. The firm has a market cap of $9.31 billion, a price-to-earnings ratio of 65.92, a price-to-earnings-growth ratio of 1.71 and a beta of 1.19.
Hinge Health (NYSE:HNGE – Get Free Report) last released its quarterly earnings results on Monday, November 2nd. The company reported $0.71 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.44. Hinge Health had a net margin of 21.02% and a return on equity of 66.96%. The business had revenue of $234.97 million for the quarter. During the same quarter in the prior year, the business posted ($0.02) EPS. The firm’s revenue for the quarter was up 52.4% compared to the same quarter last year. As a group, research analysts predict that Hinge Health Inc. will post 1.56 earnings per share for the current fiscal year.
Insider Buying and Selling at Hinge Health
In other Hinge Health news, President James Pursley sold 33,000 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $88.05, for a total transaction of $2,905,650.00. Following the transaction, the president directly owned 706,235 shares in the company, valued at $62,183,991.75. This trade represents a 4.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel Perez sold 150,000 shares of the firm’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $89.44, for a total value of $13,416,000.00. Following the transaction, the chief executive officer owned 35,470 shares in the company, valued at approximately $3,172,436.80. This trade represents a 80.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,260,488 shares of company stock valued at $124,481,770. Corporate insiders own 18.92% of the company’s stock.
Analyst Ratings Changes
A number of analysts have recently issued reports on the company. Bank of America started coverage on Hinge Health in a report on Tuesday, September 29th. They issued a “buy” rating and a $110.00 target price for the company. Stifel Nicolaus raised their target price on Hinge Health from $130.00 to $135.00 and gave the stock a “buy” rating in a research report on Tuesday, November 3rd. Robert W. Baird lifted their price target on Hinge Health from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Tuesday, September 22nd. Zacks Research raised Hinge Health from a “hold” rating to a “strong-buy” rating in a research report on Friday, November 6th. Finally, KeyCorp upped their price target on Hinge Health from $125.00 to $140.00 and gave the company an “overweight” rating in a research report on Friday, October 16th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $118.93.
Get Our Latest Stock Analysis on HNGE
Hinge Health Profile
Hinge Health is a digital health company focused on musculoskeletal care, including support for people with back, joint and muscle pain. Its services are designed to help members manage conditions through personalized, technology-enabled care. The company’s offerings include app-based exercise therapy, education and behavioral support, along with access to clinical care teams. Hinge Health also uses wearable motion sensors in some programs to guide and track exercises. Founded in 2015, Hinge Health primarily provides its services through employers and health plans.
See Also
- Five stocks we like better than Hinge Health
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding HNGE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hinge Health Inc. (NYSE:HNGE – Free Report).
Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.
